SCM
ACOR
Scopia Capital Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,773,777
| Closed | -$7.96M | – | 25 |
|
|
2019
Q3 | $7.96M | Sell |
2,773,777
-549,679
| -17% | -$1.58M | 0.47% | 17 |
|
|
2019
Q2 | $25.5M | Sell |
3,323,456
-1,136,617
| -25% | -$8.72M | 1.13% | 18 |
|
|
2019
Q1 | $59.3M | Sell |
4,460,073
-1,030,962
| -19% | -$13.7M | 2.19% | 15 |
|
|
2018
Q4 | $85.6M | Sell |
5,491,035
-1,615,920
| -23% | -$25.2M | 2.9% | 15 |
|
|
2018
Q3 | $140M | Sell |
7,106,955
-529,611
| -7% | -$10.4M | 2.69% | 14 |
|
|
2018
Q2 | $219M | Sell |
7,636,566
-838,162
| -10% | -$24.1M | 3.83% | 7 |
|
|
2018
Q1 | $200M | Hold |
8,474,728
| – | – | 4.01% | 9 |
|
|
2017
Q4 | $182M | Hold |
8,474,728
| – | – | 3.26% | 11 |
|
|
2017
Q3 | $200M | Buy |
8,474,728
+1,250,822
| +17% | +$29.6M | 3.17% | 11 |
|
|
2017
Q2 | $142M | Buy |
7,223,906
+1,655,600
| +30% | +$32.6M | 2.94% | 12 |
|
|
2017
Q1 | $117M | Buy |
5,568,306
+1,036,239
| +23% | +$21.8M | 2.16% | 16 |
|
|
2016
Q4 | $85.2M | Buy |
4,532,067
+328,061
| +8% | +$6.17M | 1.61% | 20 |
|
|
2016
Q3 | $87.8M | Buy |
4,204,006
+1,032,777
| +33% | +$21.6M | 1.55% | 19 |
|
|
2016
Q2 | $80.9M | Buy |
3,171,229
+515,696
| +19% | +$13.2M | 1.67% | 20 |
|
|
2016
Q1 | $70.2M | Buy |
2,655,533
+702,110
| +36% | +$18.6M | 1.31% | 22 |
|
|
2015
Q4 | $83.6M | Buy |
1,953,423
+1,386,125
| +244% | +$59.3M | 1.66% | 19 |
|
|
2015
Q3 | $15M | Buy |
+567,298
| New | +$15M | 0.32% | 29 |
|